These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 19875613)

  • 1. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects.
    Long SA; Cerosaletti K; Bollyky PL; Tatum M; Shilling H; Zhang S; Zhang ZY; Pihoker C; Sanda S; Greenbaum C; Buckner JH
    Diabetes; 2010 Feb; 59(2):407-15. PubMed ID: 19875613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+ CD25(hi) T cells of type 1 diabetic and multiple sclerosis patients.
    Cerosaletti K; Schneider A; Schwedhelm K; Frank I; Tatum M; Wei S; Whalen E; Greenbaum C; Kita M; Buckner J; Long SA
    PLoS One; 2013; 8(12):e83811. PubMed ID: 24376757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro.
    Yates J; Rovis F; Mitchell P; Afzali B; Tsang J; Garin M; Lechler RI; Lombardi G; Garden OA
    Int Immunol; 2007 Jun; 19(6):785-99. PubMed ID: 17545278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-15 acts as a potent inducer of CD4(+)CD25(hi) cells expressing FOXP3.
    Imamichi H; Sereti I; Lane HC
    Eur J Immunol; 2008 Jun; 38(6):1621-30. PubMed ID: 18493981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased regulatory function of CD4
    Sheikh V; Zamani A; Mahabadi-Ashtiyani E; Tarokhian H; Borzouei S; Alahgholi-Hajibehzad M
    Scand J Immunol; 2018 Oct; 88(4):e12711. PubMed ID: 30270447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.
    Sobel ES; Brusko TM; Butfiloski EJ; Hou W; Li S; Cuda CM; Abid AN; Reeves WH; Morel L
    Arthritis Res Ther; 2011 Jun; 13(3):R106. PubMed ID: 21708033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T regulatory lymphocytes in type 1 diabetes: Impaired CD25 expression and IL-2 induced STAT5 phosphorylation in pediatric patients.
    Parackova Z; Kayserova J; Danova K; Sismova K; Dudkova E; Sumnik Z; Kolouskova S; Lebl J; Stechova K; Sediva A
    Autoimmunity; 2016 Dec; 49(8):523-531. PubMed ID: 27560779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Depressive effect of cigarette smoke extracts on dendritic cells inducing differentiation of CD4+T cells into CD4+CD25+Foxp3+ Tregs].
    Liang Y; Zhou G; Zhang L; Liu J; Zhong X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jan; 32(1):15-9. PubMed ID: 26728371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta.
    Scholzen A; Mittag D; Rogerson SJ; Cooke BM; Plebanski M
    PLoS Pathog; 2009 Aug; 5(8):e1000543. PubMed ID: 19680449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of human regulatory T-cells from patients with type 1 diabetes.
    Putnam AL; Brusko TM; Lee MR; Liu W; Szot GL; Ghosh T; Atkinson MA; Bluestone JA
    Diabetes; 2009 Mar; 58(3):652-62. PubMed ID: 19074986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose IL-2 expands CD4
    Li Y; Liu X; Wang W; Wang S; Zhang J; Jiang S; Wang Y; Li L; Li J; Zhang Y; Huang H
    Ren Fail; 2018 Nov; 40(1):280-288. PubMed ID: 29619880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro Conversion into CD4+CD25+Foxp3+ Induced Regulatory T Cells Is Reduced in Atopic Dermatitis Patients.
    García EM; Galicia-Carreón J; Novak N
    Int Arch Allergy Immunol; 2020; 181(5):353-356. PubMed ID: 32160611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alternation of autophagy/apoptosis in CD4+CD25+Foxp3+ Tregs on the developmental stages of atherosclerosis.
    Tian Y; Liang X; Wu Y
    Biomed Pharmacother; 2018 Jan; 97():1053-1060. PubMed ID: 29136784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modified flow cytometry method for objective estimation of human CD4
    Petsiou A; Paschou SA; Vartholomatos G; Chatzigianni K; Kolaitis N; Giotaki E; Bondinas GP; Moustakas AK; Karamoutsios A; Zervou E; Tigas S; Tsatsoulis A; Papadopoulos GK
    Cytometry B Clin Cytom; 2020 May; 98(3):259-269. PubMed ID: 31571372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Modulation of Regulatory T Cells by IL-2.
    Moon BI; Kim TH; Seoh JY
    PLoS One; 2015; 10(11):e0141864. PubMed ID: 26529512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
    Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
    J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-33 Effect on Quantitative Changes of CD4
    Ryba-Stanisławowska M; Werner P; Skrzypkowska M; Brandt A; Myśliwska J
    Mediators Inflamm; 2016; 2016():9429760. PubMed ID: 27761063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes.
    Brusko T; Wasserfall C; McGrail K; Schatz R; Viener HL; Schatz D; Haller M; Rockell J; Gottlieb P; Clare-Salzler M; Atkinson M
    Diabetes; 2007 Mar; 56(3):604-12. PubMed ID: 17327427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.